Samtidig administration af irbesartan ændrer det kalium- tab, der er forbundet med disse diuretika, formodentligt ved at blokere renin- angiotensin- aldosteronsystemet.
Presumably through blockade of the renin-angiotensin-aldosterone system, co-administration of irbesartan tends to reverse the potassium loss associated with these diuretics.